Trial site
Women's Cancer Center of Seattle
Seattle, Washington 98133, United StatesNot linked to an institution yet
- 4running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Phase
- Phase 33 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Suspended1 trial
- Lead sponsor
- National Cancer Institute (NCI)5 trials
- GOG Foundation1 trial
- NRG Oncology1 trial
Running trials
Active, not recruiting
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
NCT02502266· Phase 2/3· National Cancer Institute (NCI)· Source
Active, not recruiting
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02446600· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
NCT02257528· Phase 2· National Cancer Institute (NCI)· Source
Active, not recruiting
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851· Phase 3· National Cancer Institute (NCI)· Source
Report an error